⌘K

16:15:14·1166d

SECFilingvia Quantisnow

Virios Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure

ByQuantisnow·Wall Street's wire, on your screen.

VIRI· Virios Therapeutics Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

SEC Form SC 13D filed by Virios Therapeutics Inc.
SEC Form DEFA14A filed by Virios Therapeutics Inc.
Virios Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Leadership Update, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: "DWTX")
SEC Form 10-Q filed by Virios Therapeutics Inc.